Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunkyu Kim

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Database : the Journal of Biological Databases and Curation|September 25, 2025
Automatic genetic phenotype normalization from dysmorphology physical examinations: an overview of the BioCreative VIII-Task 3 competitionDavy Weissenbacher, Xinwei Zhao, Jessica R C Priestley, et al.
Journal of Medicinal Chemistry|January 8, 2025
Discovery of INCB159020, an Orally Bioavailable KRAS G12D InhibitorQinda Ye, Artem Shvartsbart, Zhenwu Li, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 InhibitorsYoung Shin Cho, Hayley Angove, Christopher Brain, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Nature|October 19, 2017
Molecular basis of USP7 inhibition by selective small-molecule inhibitorsAndrew P Turnbull, Stephanos Ioannidis, Wojciech W Krajewski, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Database : the Journal of Biological Databases and Curation|September 25, 2025
Automatic genetic phenotype normalization from dysmorphology physical examinations: an overview of the BioCreative VIII-Task 3 competitionDavy Weissenbacher, Xinwei Zhao, Jessica R C Priestley, et al.
Journal of Medicinal Chemistry|January 8, 2025
Discovery of INCB159020, an Orally Bioavailable KRAS G12D InhibitorQinda Ye, Artem Shvartsbart, Zhenwu Li, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 InhibitorsYoung Shin Cho, Hayley Angove, Christopher Brain, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Nature|October 19, 2017
Molecular basis of USP7 inhibition by selective small-molecule inhibitorsAndrew P Turnbull, Stephanos Ioannidis, Wojciech W Krajewski, et al.
Pageof 7